Atıf Formatları
The Impact of Lamuvidine Therapy on Patient and graft survival in HbsAg positive Kidney Allograft Recipients
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

V. T. YILMAZ, "The Impact of Lamuvidine Therapy on Patient and graft survival in HbsAg positive Kidney Allograft Recipients," XLVII ERA-EDTA CONGRESS -II DGfN CONGRESS , Munich, Germany, pp.70, 2010

YILMAZ, V. T. 2010. The Impact of Lamuvidine Therapy on Patient and graft survival in HbsAg positive Kidney Allograft Recipients. XLVII ERA-EDTA CONGRESS -II DGfN CONGRESS , (Munich, Germany), 70.

YILMAZ, V. T., (2010). The Impact of Lamuvidine Therapy on Patient and graft survival in HbsAg positive Kidney Allograft Recipients . XLVII ERA-EDTA CONGRESS -II DGfN CONGRESS (pp.70). Munich, Germany

YILMAZ, VURAL. "The Impact of Lamuvidine Therapy on Patient and graft survival in HbsAg positive Kidney Allograft Recipients," XLVII ERA-EDTA CONGRESS -II DGfN CONGRESS, Munich, Germany, 2010

YILMAZ, VURAL T. . "The Impact of Lamuvidine Therapy on Patient and graft survival in HbsAg positive Kidney Allograft Recipients." XLVII ERA-EDTA CONGRESS -II DGfN CONGRESS , Munich, Germany, pp.70, 2010

YILMAZ, V. T. (2010) . "The Impact of Lamuvidine Therapy on Patient and graft survival in HbsAg positive Kidney Allograft Recipients." XLVII ERA-EDTA CONGRESS -II DGfN CONGRESS , Munich, Germany, p.70.

@conferencepaper{conferencepaper, author={VURAL TANER YILMAZ}, title={The Impact of Lamuvidine Therapy on Patient and graft survival in HbsAg positive Kidney Allograft Recipients}, congress name={XLVII ERA-EDTA CONGRESS -II DGfN CONGRESS}, city={Munich}, country={Germany}, year={2010}, pages={70} }